Drug Pipeline

Navitoclax Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
0
Recruiting
1
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 1/2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04468984 Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best… Myelofibrosis (MF) Active, Not Recruiting
Phase 1/2
NCT01989585 Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in… Clinical Stage III Cutaneous Melanoma AJCC v8 Active, Not Recruiting
NCT02079740 Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors Metastatic Malignant Solid Neoplasm Active, Not Recruiting
Phase 1
NCT05455294 Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms Myeloid Malignancy Active, Not Recruiting
NCT05222984 Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute… Recurrent Acute Myeloid Leukemia Active, Not Recruiting
Sponsors Running Navitoclax Trials
National Cancer Institute (NCI) (2) AbbVie (1) City of Hope Medical Center (1) Jacqueline Garcia, MD (1)
Disease Areas
Myelofibrosis (2) Leukemia (2) Acute Myeloid Leukemia (AML) (2) Melanoma (1) Myelodysplastic Syndromes (MDS) (1)
Get alerts when Navitoclax trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free